Company Profile-Hubei Aivide Technology Co., Ltd

Company Profile

Hubei Aivide Technology Co., Ltd is a technology-based enterprise specializing in animal disease diagnosis and food safety testing. The company is committed to providing high-quality disease diagnosis and epidemic prevention testing products for the animal husbandry industry; Provide reliable clinical diagnostic products for companion animals; Provide high-quality, convenient and fast testing products for food safety testing.

Hubei Aivide Products has strong R&D capabilities and currently has a dedicated R&D team of 10 people, including 4 with doctoral or above degrees, 2 with master's degrees, and 4 with bachelor's degrees. The project leader has been engaged in the research and development and production management of in vitro diagnostic reagents for 17 years. The team members are all professionals in related fields, and have worked in internationally renowned in vitro diagnostic reagent units such as Hangzhou Aikang and Shengxiang Biology. They have rich experience in research and development and technology transformation. At the same time, Kangzhou Medical attaches great importance to cooperation between industry, academia, and research. It has carried out project development cooperation with pet hospitals of Huazhong Agricultural University, medical schools of Hubei University of Science and Technology, and other universities. On this basis, it has jointly established a joint training base for professional direct talent.

Hubei Aivide has four leading domestic technology platforms in the field of in vitro diagnostic reagents: fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence, colloidal gold, and dry chemistry; The company's products cover over 60 in vitro diagnostic products for diseases applicable to companion animals (dogs, cats) and economic animals (pigs, cows, sheep, and poultry). The performance of the products has been comprehensively evaluated by multiple high-level laboratories and has been unanimously recognized. As of now, the company is applying for 18 independent intellectual property rights, including 4 invention patents, 13 utility model patents, and 1 software copyright.

Since its establishment, the company has always adhered to the concept of "improving product performance, improving quality control capabilities, and improving service quality always on the way", committed to transforming advanced technology and the pursuit of extreme attitude into high-quality products and services, helping users improve the accuracy and convenience of disease diagnosis and prevention, and providing users with the best solutions.

Development History

2023-9

After long-term technological optimization and product validation, relying on existing technological platforms for transformation, we have produced related products such as canine distemper virus antigen screening products, canine coronavirus antigen screening products, canine parvovirus antigen screening products, cat distemper virus antigen screening products, cat blister virus antigen screening products, cat calicivirus antigen screening products, etc

2023-6

The construction of a clean production workshop provides a safe, clean, stable, and high-quality environment for the production of high-quality products.

2023-3

The company attaches great importance to cooperation between industry, academia, and research, and has conducted project development cooperation with pet hospitals of Huazhong Agricultural University, medical schools of Hubei University of Science and Technology, and other universities

2023-1

After 5 years of polishing and sedimentation, Wuhan Kangzhou Medical Technology Co., Ltd. was established, focusing on animal disease diagnosis and food safety testing

2022-2

Research and development of pet products

2021-4

The dividends of COVID-19 slowly dissipated. After continuous discussion and long-term research, the team members decided to transform from human reagents to research and development of pet and veterinary reagents. Based on the research and development of cattle, sheep, and poultry testing products, we aim to improve the accuracy and convenience of animal disease diagnosis and prevention.

2020-5

Due to the impact of the novel coronavirus epidemic, the R&D personnel spare no effort to develop COVID-19 antibody and antigen detection products, and cooperate with related companies to provide technical guidance and output.

2019-4

Research and development of human infectious disease detection products

2018-10

Starting from the research and development of inflammation detection products, we aim to build a team with advanced technology and a pursuit of extreme attitude.

2018-6

IVD platform construction: gather ambitious individuals, sharpen the sword of health, gather outstanding talents in fields such as fluorescence quantitative chromatography (POCT), magnetic particle tube chemiluminescence, colloidal gold, and dry chemistry, and forge ahead.